Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Iron sucrose (Sucroferric oxyhydroxide) is treatment of iron deficiency anemia.
パッケージサイズ | 在庫状況 | 単価(税別) | |||
---|---|---|---|---|---|
サンプルについてお問い合わせ | |||||
100 mg | 在庫あり | ¥ 9,000 | |||
200 mg | 在庫あり | ¥ 13,000 | |||
500 mg | 在庫あり | ¥ 21,000 | |||
1 mL * 10 mM (in DMSO) | 在庫あり | ¥ 9,000 |
説明 | Iron sucrose (Sucroferric oxyhydroxide) is treatment of iron deficiency anemia. |
In vitro | In vitro conditions iron induces a dose-dependent inhibition of viability of the mesothelial cells as reflected by inhibition of the cells growth by 34% at Fe 0.1 mg mL-1 vs. control (P |
細胞研究 | in vitro experiments on human peritoneal, the mesothelial effect of elemental iron (in conc. 0.0001-1 mg mL-1) present in Venofer on their viability, growth and synthesis of IL-6 was studied. Additionally we evaluated with a fluorescent probe (2',7'-dichlorodihydro-fluorescein diacatate) generation of reactive oxygen species in cells exposed to iron sucrose. We also measured accumulation of iron in the cytoplasm of mesothelial cells after their in vitro exposure to Venofer[1]. |
別名 | Iron saccharate, Sucroferric oxyhydroxide |
分子量 | 736.1 |
分子式 | C18H24Fe2O24 |
CAS No. | 8047-67-4 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 60 mg/mL (81.51 mM)
H2O: 100 mg/mL (135.85 mM)
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Iron sucrose 8047-67-4 Immunology/Inflammation Metabolism NF-Κb Reactive Oxygen Species H2O2 pregnancy ascorbate IDA Intravenous ICAM-1 inhibit NADPH NF-κB Inhibitor VCAM-1 hemoglobin anemia Iron saccharate iron Sucroferric oxyhydroxide safe inhibitor